These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

430 related items for PubMed ID: 15537453

  • 21. Characteristics and response to antiretroviral therapy of HIV-1-infected patients born in Africa and living in France.
    Breton G, Lewden C, Spire B, Salmon D, Brun-Vézinet F, Duong M, Allavena C, Leport C, Salamon R, APROCO COPILOTE ANRS CO8 Study Group.
    HIV Med; 2007 Apr; 8(3):164-70. PubMed ID: 17461860
    [Abstract] [Full Text] [Related]

  • 22. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
    Palombi L, Marazzi MC, Voetberg A, Magid NA.
    AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
    [Abstract] [Full Text] [Related]

  • 23. Are the best antiretrovirals being used in Africa?
    John L, Kambugu A, Songa PM, Castelnuovo B, Colebunders R, Kamya M.
    J HIV Ther; 2006 Mar; 11(1):11-5. PubMed ID: 16706250
    [No Abstract] [Full Text] [Related]

  • 24. Providing HIV care for co-infected tuberculosis patients: a perspective from sub-Saharan Africa.
    Harries AD, Zachariah R, Lawn SD.
    Int J Tuberc Lung Dis; 2009 Jan; 13(1):6-16. PubMed ID: 19105873
    [Abstract] [Full Text] [Related]

  • 25. The emerging crisis of drug-resistant tuberculosis in South Africa: lessons from New York City.
    Murphy RA.
    Clin Infect Dis; 2008 Jun 01; 46(11):1729-32. PubMed ID: 18426372
    [Abstract] [Full Text] [Related]

  • 26. Strategies for the scale-up of antiretroviral therapy in South Africa through health system optimization.
    Barker PM, McCannon CJ, Mehta N, Green C, Youngleson MS, Yarrow J, Bennett B, Berwick DM.
    J Infect Dis; 2007 Dec 01; 196 Suppl 3():S457-63. PubMed ID: 18181694
    [Abstract] [Full Text] [Related]

  • 27. Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission.
    Elzi L, Schlegel M, Weber R, Hirschel B, Cavassini M, Schmid P, Bernasconi E, Rickenbach M, Furrer H, Swiss HIV Cohort Study.
    Clin Infect Dis; 2007 Jan 01; 44(1):94-102. PubMed ID: 17143823
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment.
    Corbett EL, Marston B, Churchyard GJ, De Cock KM.
    Lancet; 2006 Mar 18; 367(9514):926-37. PubMed ID: 16546541
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. HIV/AIDS care and treatment in sub-Saharan Africa.
    Kassaye SG, Katzenstein D.
    AIDS Rev; 2003 Mar 18; 5(4):195-204. PubMed ID: 15011998
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Research as a path to wide-scale implementation of antiretroviral therapy in Africa.
    Sanne I, van der Horst C.
    J HIV Ther; 2004 Sep 18; 9(3):65-8. PubMed ID: 15534564
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.